Emerging role of microRNAs in lipid metabolism

Acta Pharmaceutica Sinica B

Volumn 5, Issue 2, 2015, Pages 145-150

  Yang, Zhihong ^a,b   Cappello, Tyler ^a   Wang, Li ^a,b,c  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lipid metabolism; MicroRNAs; Nuclear receptors

Indexed keywords

CELL NUCLEUS RECEPTOR; FARNESOID X RECEPTOR; FATTY ACID; LIPID; LIPOPROTEIN; MICRORNA; MICRORNA 122; MICRORNA 21; MICRORNA 27A; MICRORNA 27B; MICRORNA 33; MICRORNA 34A; MICRORNA 378; SIRTUIN 1; SMALL UNTRANSLATED RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

EPIGENETICS; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC REGULATION; HUMAN; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN SECRETION; METABOLIC SYNDROME X; REVIEW; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

EID: 84947202484     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2015.01.002     Document Type: Review

References (72)

1. Yang Z.H., Wang L. Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci 2011, 1:31.
2. Yang J.S., Lai E.C. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell 2011, 43:892-903.
3. * strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule?. PLoS One 2010, 5:e11387.
4. Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014, 15:509-524.
5. Cheloufi S., Dos Santos C.O., Chong M.M., Hannon G.J. A Dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010, 465:584-589.
6. Cifuentes D., Xue H.L., Taylor D.W., Patnode H., Mishima Y., Cheloufi S., et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010, 328:1694-1698.
7. Wang H., Smith G.W., Yang Z., Jiang Y., McCloskey M., Greenberg K., et al. Short hairpin RNA-mediated knockdown of Vegfa in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity. Am J Pathol 2013, 183:964-974.
8. Yang Z., Wang H., Jiang Y., Hartnett M.E. VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis. Am J Pathol 2014, 184:1230-1239.
9. Cui X.S., Zhang D.X., Ko Y.G., Kim N.H. Aberrant epigenetic reprogramming of imprinted microRNA-127 and Rtl1 in cloned mouse embryos. Biochem Biophys Res Commun 2009, 379:390-394.
10. Song G., Wang L. Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRγ. Nucleic Acids Res 2008, 36:5727-5735.
11. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9:435-443.
12. Song G., Wang L. miR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus. PLoS One 2008, 3:e3574.
13. Song G., Wang L. A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals. PLoS One 2009, 4:e7829.
14. Song G., Wang L. Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism. PLoS One 2009, 4:e6880.
15. Song G., Zhang Y., Wang L. microRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 2009, 284:31921-31927.
16. Zhang Y., Hagedorn C.H., Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011, 1812:893-908.
17. Li J., Zhang Y., Kuruba R., Gao X., Gandhi C.R., Xie W., et al. Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol 2011, 80:191-200.
18. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., et al. micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
19. Lee C.G., Kim Y.W., Kim E.H., Meng Z., Huang W., Hwang S.J., et al. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology 2012, 142:1206-1217. (e7).
20. Yang Z., Tsuchiya H., Zhang Y., Hartnett M.E., Wang L. microRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem 2013, 288:28893-28899.
21. Yang Z., Zhang Y., Wang L. A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP13. PLoS One 2013, 8:e65256.
22. Zhang Y., Yang Z., Whitby R., Wang L. Regulation of miR-200c by nuclear receptors PPARα, LRH-1 and SHP. Biochem Biophys Res Commun 2011, 416:135-139.
23. Herzig S., Hedrick S., Morantte I., Koo S.H., Galimi F., Montminy M. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ. Nature 2003, 426:190-193.
24. Estep M., Armistead D., Hossain N., Elarainy H., Goodman Z., Baranova A., et al. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010, 32:487-497.
25. Lavoie J.M., Gauthier M.S. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci 2006, 63:1393-1409.
26. Beaven S.W., Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 2006, 57:313-329.
27. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006, 3:87-98.
28. Nikel P.I., Kim J., de Lorenzo V. Metabolic and regulatory rearrangements underlying glycerol metabolism in Pseudomonas putida KT2440. Environ Microbiol 2014, 16:239-254.
29. Tsai W.C., Hsu S.D., Hsu C.S., Lai T.C., Chen S.J., Shen R., et al. microRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012, 122:2884-2897.
30. Szabo G., Bala S. microRNAs in liver disease. Nat Rev Gastroenterol Hepatol 2013, 10:542-552.
31. Hsu S.H., Wang B., Kota J., Yu J., Costinean S., Kutay H., et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 2012, 122:2871-2883.
32. Sacco J., Adeli K. microRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol 2012, 23:220-225.
33. Gatfield D., Le Martelot G., Vejnar C.E., Gerlach D., Schaad O., Fleury-Olela F., et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 2009, 23:1313-1326.
34. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005, 309:1577-1581.
35. Thomas M., Deiters A. microRNA miR-122 as a therapeutic target for oligonucleotides and small molecules. Curr Med Chem 2013, 20:3629-3640.
36. Sun X., Feinberg M.W. microRNA-management of lipoprotein homeostasis. Circ Res 2014, 115:2-6.
37. Najafi-Shoushtari S.H., Kristo F., Li Y., Shioda T., Cohen D.E., Gerszten R.E., et al. microRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
38. Jeon T.I., Osborne T.F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 2012, 23:65-72.
39. Rayner K.J., Suárez Y., Dávalos A., Parathath S., Fitzgerald M.L., Tamehiro N., et al. miR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
40. Marquart T.J., Allen R.M., Ory D.S., Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010, 107:12228-12232.
41. Horie T., Ono K., Horiguchi M., Nishi H., Nakamura T., Nagao K., et al. microRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (SREBP2) regulates HDL in vivo. Proc Natl Acad Sci USA 2010, 107:17321-17326.
42. Horie T., Nishino T., Baba O., Kuwabara Y., Nakao T., Nishiga M., et al. microRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun 2013, 4:2883.
43. * in controlling lipid metabolism gene expression. Mol Cell Biol 2013, 33:2339-2352.
44. Goedeke L., Salerno A., Ramírez C.M., Guo L., Allen R.M., Yin X., et al. Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol Med 2014, 6:1133-1141.
45. Allen R.M., Marquart T.J., Jesse J.J., Baldán A. Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33. Circ Res 2014, 115:10-22.
46. Rayner K.J., Esau C.C., Hussain F.N., McDaniel A.L., Marshall S.M., van Gils J.M., et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478:404-407.
47. Ji J., Zhang J., Huang G., Qian J., Wang X., Mei S. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009, 583:759-766.
48. Jennewein C., von Knethen A., Schmid T., Brune B. microRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor γ (PPARγ) mRNA destabilization. J Biol Chem 2010, 285:11846-11853.
49. Wang T., Li M., Guan J., Li P., Wang H., Guo Y., et al. microRNAs miR-27a and miR-143 regulate porcine adipocyte lipid metabolism. Int J Mol Sci 2011, 12:7950-7959.
50. Shirasaki T., Honda M., Shimakami T., Horii R., Yamashita T., Sakai Y., et al. microRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J Virol 2013, 87:5270-5286.
51. *. Proc Natl Acad Sci USA 2012, 109:15330-15335.
52. (*) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. Cell Metab 2010, 12:352-361.
53. Knezevic I., Patel A., Sundaresan N.R., Gupta M.P., Solaro R.J., Nagalingam R.S., et al. A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival. J Biol Chem 2012, 287:12913-12926.
54. Wang D., Yan X., Xia M., Yang Y., Li D., Li X., et al. Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1/miR-378/ATP-binding cassette transporter G1-signaling pathway. Arterioscler Thromb Vasc Biol 2014, 34:1860-1870.
55. Pizzimenti S., Ferracin M., Sabbioni S., Toaldo C., Pettazzoni P., Dianzani M.U., et al. microRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic Biol Med 2009, 46:282-288.
56. * in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab 2010, 299:E198-E206.
57. John E., Wienecke-Baldacchino A., Liivrand M., Heinäniemi M., Carlberg C., Sinkkonen L. Dataset integration identifies transcriptional regulation of microRNA genes by PPARγ in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res 2012, 40:4446-4460.
58. Kulyté A., Lorente-Cebrián S., Gao H., Mejhert N., Agustsson T., Arner P., et al. microRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia. Am J Physiol Endocrinol Metab 2014, 306:E267-E274.
59. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26:731-743.
60. Chen F., Hu S.J. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol 2012, 26:79-86.
61. Lee J., Padhye A., Sharma A., Song G., Miao J., Mo Y.Y., et al. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 2010, 285:12604-12611.
62. + levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 2013, 12:1062-1072.
63. Oda Y., Nakajima M., Tsuneyama K., Takamiya M., Aoki Y., Fukami T., et al. Retinoid X receptor α in human liver is regulated by miR-34a. Biochem Pharmacol 2014, 90:179-187.
64. Fu T., Seok S., Choi S., Huang Z., Suino-Powell K., Xu H.E., et al. microRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol 2014, 34:4130-4142.
65. Ahn J., Lee H., Jung C.H., Ha T. Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet. Mol Nutr Food Res 2012, 56:1665-1674.
66. Chau B.N., Xin C., Hartner J., Ren S., Castano A.P., Linn G., et al. microRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 2012, 4:121ra18.
67. Kida K., Nakajima M., Mohri T., Oda Y., Takagi S., Fukami T., et al. PPARα is regulated by miR-21 and miR-27b in human liver. Pharm Res 2011, 28:2467-2476.
68. Feng J., Li A.T., Deng J.Y., Yang Y.H., Dang L.L., Ye Y.P., et al. miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease. Lipids Health Dis 2014, 13:27.
69. Fabani M.M., Gait M.J. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 2008, 14:336-346.
70. Wang L., Tang W., Yan S., Zhou L., Shen T., Huang X., et al. Efficient delivery of miR-122 to regulate cholesterol metabolism using a non-covalent peptide-based strategy. Mol Med Rep 2013, 8:1472-1478.
71. Wang X., Yu B., Ren W., Mo X., Zhou C., He H., et al. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release 2013, 172:690-698.
72. Boon R.A., Vickers K.C. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 2013, 33:186-192.